Portal:COVID-19/CoveredPWs
From WikiPathways
(Difference between revisions)
| Line 45: | Line 45: | ||
|} | |} | ||
| + | === Pathway categories === | ||
The pathways on this portal are grouped in the following categories: SARS-CoV-2 Pathways, Other coronaviruses (e.g. MERS, SARS-CoV) and virus-host specific interactions (e.g. ACE2). | The pathways on this portal are grouped in the following categories: SARS-CoV-2 Pathways, Other coronaviruses (e.g. MERS, SARS-CoV) and virus-host specific interactions (e.g. ACE2). | ||
| + | |||
| + | === Contact us === | ||
| + | Send questions about WikiPathways to the [mailto:wikipathways-discuss@googlegroups.com wikipathways-discuss mailing list]. | ||
| + | |||
| + | === How to add a pathway to the portal === | ||
| + | |||
| + | The list of Featured Pathways is not static and can be updated at any time. If you know of a pathway that should be added, please [mailto:martina.kutmon@maastrichtuniversity.nl contact the administrator]. | ||
| + | |||
| + | * See our Help section for [[:Help:New_Contributor_Quickstart|New Contributor QuickStart]], [[:Help:Guidelines_EditorPalette|Editor's Palette Guide]] and [[:Help:Guidelines|Guidelines for Contributors]]. | ||
Revision as of 19:29, 9 September 2020
| Title | Links WP | Category | Status |
|---|---|---|---|
| SARS-CoV-2 and COVID-19 Pathway | WP4846 | SARS-CoV-2 Pathways | Approved |
| Hijack of Ubiquitination by SARS-CoV-2 | WP4860 | SARS-CoV-2 Pathways | Approved |
| Type I Interferon Induction and Signaling During SARS-CoV-2 Infection | WP4868 | SARS-CoV-2 Pathways | In Progress |
| COVID-19, thrombosis and anticoagulation | WP4927 | SARS-CoV-2 Pathways | In Progress |
| Activation of NLRP3 Inflammasome by SARS-CoV-2 | WP4876 | SARS-CoV-2 Pathways | In Progress |
| SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor: Molecular mechanisms and potential therapeutic target | WP4883 | SARS-CoV-2 Pathways | In Progress |
| COVID-19 AOP | WP4891 | SARS-CoV-2 Pathways | In Progress |
| nsp9/nsp10-mediated SARS-CoV-2 pathogenesis | WP4884 | SARS-CoV-2 Pathways | In Progress |
| LDLRAD4 pathway in COVID-19 | WP4904 | SARS-CoV-2 Pathways | In Progress |
| Overview of perturbations to host-cell autophagy, induced by distinct proteins of SARS-CoV-2 | WP4936 | SARS-CoV-2 Pathways | In Progress |
| Coronavirus lipid metabolism | WP4853 | Other coronaviruses | In Progress |
| Host-pathogen interaction of human corona viruses - autophagy | WP4863 | Other coronaviruses | In Progress |
| Host-pathogen interaction of human corona viruses - apoptosis | WP4864 | Other coronaviruses | In Progress |
| SARS coronavirus and innate immunity | WP4912 | Other coronaviruses | In Progress |
| ER stress response in Coronavirus infection | WP4861 | Other coronaviruses | In Progress |
| Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein | WP4799 | Other coronaviruses | In Progress |
| Host-pathogen interaction of human corona viruses - MAPK signaling | WP4877 | Other coronaviruses | In Progress |
| Host-pathogen interaction of human corona viruses - Interferon induction | WP4880 | Other coronaviruses | In Progress |
| ACE Inhibitor Pathway | WP554 | ACE2 | In Progress |
| Metabolism of Angiotensinogen to Angiotensins (Reactome) | WP2729 | ACE2 | In Progress |
Pathway categories
The pathways on this portal are grouped in the following categories: SARS-CoV-2 Pathways, Other coronaviruses (e.g. MERS, SARS-CoV) and virus-host specific interactions (e.g. ACE2).
Contact us
Send questions about WikiPathways to the wikipathways-discuss mailing list.
How to add a pathway to the portal
The list of Featured Pathways is not static and can be updated at any time. If you know of a pathway that should be added, please contact the administrator.
- See our Help section for New Contributor QuickStart, Editor's Palette Guide and Guidelines for Contributors.
